Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver.
A system is described for the detailed study of the remodeling of hepatic nodules that appear regularly during liver carcinogenesis with chemicals. With the use of the resistant hepatocyte model and by focusing on the caudate lobe, it has been possible to label with [3H]thymidine all the hepatocytes in hepatocyte nodules without any significant degree of labeling of the surrounding hepatocytes. Through such a model, the persistence of the label, in relation to the organization and appearance of the hepatocytes in the nodules, has been followed for 26 weeks. Nodules do not "disappear" to any significant degree by regression or by replacement with hepatocytes from the surrounding liver. Rather, nodule hepatocytes undergo differentiation to an adult liver phenotype. Thus, differentiation ("redifferentiation") of a carcinogen-induced altered hepatocyte population is seen regularly during carcinogenesis despite the irreversible nature of some of the changes induced by a chemical carcinogen during initiation.
D015073:2-Acetylaminofluorene / Q000633:toxicity*; D000217:Acyltransferases / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation; D004261:DNA Replication; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D013936:Thymidine / Q000378:metabolism; D011503:Transglutaminases
D015073:2-Acetylaminofluorene; D000217:Acyltransferases; D011503:Transglutaminases; D013936:Thymidine